Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Long-Term Debt Repayments (2024 - 2025)

Tandem Diabetes Care's Long-Term Debt Repayments history spans 3 years, with the latest figure at -$40.8 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments changed N/A year-over-year to -$40.8 million; the TTM value through Sep 2025 reached $40.8 million, changed N/A, while the annual FY2018 figure was $87.7 million, N/A changed from the prior year.
  • Long-Term Debt Repayments reached -$40.8 million in Q4 2025 per TNDM's latest filing, down from $40.8 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $246.1 million in Q1 2024 to a low of -$246.1 million in Q3 2024.